HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• ICER report questions value of myeloma regimens, but critics say findings don’t translate to practice
• Coming out for better care: Improving cancer treatment for LGBT patients Nelson Sanchez, MD
• Argentine tango improves balance in cancer survivors with chemotherapy-induced peripheral neuropathy
• ASH names training program participants
• Association of American Cancer Institutes elects three board members
• ASTRO presents research awards to four scientists
• Fox Chase Cancer Center announces staff appointments
• Physical inactivity may be independent risk, prognostic factor for ovarian cancer
• Report: US makes progress with cancer prevention policies, but some states still fall short
• Sanford Burnham Prebys Medical Discovery Institute appoints assistant professor
• Missing emails: How we set the record straight John Sweetenham, MD, FRCP, FACP
• FDA approves Arzerra combination for relapsed CLL
• FDA approves Blincyto for pediatric relapsed, refractory B-cell precursor ALL
• Are the holiday baskets really worth the risk?
• Any coffee intake may decrease risk for colorectal cancer
• ASCO: Biomarker assays demonstrate utility for early-stage invasive breast cancer
• Black breast cancer survivors more likely to undergo autologous breast reconstruction after mastectomy
• Blue ribbon panel presents research road map for cancer moonshot initiative
• Combined chemotherapy, radiation prolongs PFS, OS in grade 2 gliomas
• Continuous lenalidomide, dexamethasone improves PFS, OS for multiple myeloma across age groups
• Cord blood transplant reduces chronic GVHD, late infection rates
• Epstein–Barr virus status affects GVHD risk after HSCT
• ESR1 mutations may influence treatment, outcomes in metastatic breast cancer
• Higher fiber intake reduces risk for breast cancer
• Lifestyle changes can reduce cancer incidence, mortality
• Obesity, overweight duration tied to cancer risk in women
• Outcomes vary in children with lower extremity DVT based on triggering event, sex
• Patients with AML remain at risk for late recurrence after HSCT
• Power morcellation use declines following FDA safety warning
• Pregnancy does not increase Hodgkin’s lymphoma relapse risk
• Radiotherapy slightly increases risk for secondary malignancies among men with prostate cancer
• Researchers: Genetic testing should be standard for metastatic prostate cancer
• Risk factors identified for skin cancer mortality after organ transplant
• Role of vemurafenib for hairy cell leukemia remains uncertain
• Romiplostim induces platelet response in pediatric immune thrombocytopenia
• Sexual dysfunction common among patients with myeloproliferative neoplasms
• Sickle cell trait increases risk for rhabdomyolysis, not death
• Use of EHRs, CPOE associated with physician burnout, dissatisfaction
• Switch from quadrivalent to 9-valent vaccine could reduce HPV prevalence
• Anxiety, depression common in family caregivers of patients with cancer
• Cancer caregivers often face great burdens, work long hours
• Early palliative care improves quality of life, frequency of end-of-life discussions
• IMRT appears safe, effective at 5-year follow-up in early-stage breast cancer
• Should patients with multiple myeloma receive continuous therapy?